191
Views
7
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphoma

, , , &
Pages 2116-2124 | Received 06 Aug 2008, Accepted 23 Sep 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yujie Jiang, Jiqing Song, Na Wang, Dai Yuan, Lili Feng, Huiting Qu & Juan Fan. (2020) Rituximab-induced acute thrombocytopenia in patients with splenomegaly B Cell lymphoma: an underdiagnosed but severe complication. Cancer Biology & Therapy 21:11, pages 1060-1066.
Read now
Ron Ram & Pia Raanani. (2008) Rituximab – a double-edged sword: can one treatment for thrombocytopenia also induce it?. Leukemia & Lymphoma 49:11, pages 2035-2036.
Read now

Articles from other publishers (5)

Adam C Robinson & Victoria R Nachar. (2019) Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma. Journal of Oncology Pharmacy Practice 26:5, pages 1248-1253.
Crossref
M. Bobot, M. Benzaquen, F. Rouby, D. Lebowitz, J. Serratrice & J.-M. Durand. (2017) Un cas de thrombopénie aiguë au rituximab dans la leucémie lymphoïde chronique. La Revue de Médecine Interne 38:5, pages 344-346.
Crossref
Reyad Dada, Jamal Zekri, Bilal Ramal & Kamel Ahmad. (2014) Acute jugular vein thrombosis during rituximab administration: Review of the literature. Journal of Oncology Pharmacy Practice 22:1, pages 165-169.
Crossref
Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse, Maarten J. ten Berg, Sabine M. J. M. Straus, Hubert G. M. Leufkens, Wouter W. van Solinge & Toine C. G. Egberts. (2012) Rituximab‐induced thrombocytopenia: a cohort study. European Journal of Haematology 89:3, pages 256-266.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.